Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...
St. Jude Medical (STJ) received an FDA safety alert for its Amplatzer ASO, a minimally-invasive implantable cardiac device used to treat atrial septal defect. The problem? In one to three of every ...
The cardiologist determines what size Amplatzer occluder to use by inflating a small balloon within the defect, and measuring the indentation in the balloon created by the defect. The Amplatzer ...
St. Jude Medical ($STJ) got sideswiped with an FDA safety alert over one of the company's heart plugs based on reports that it could potentially wear away tissue and ...
Bern, Switzerland - In an unorthodox procedure, Dr Bernhard Meier (Swiss Cardiovascular Center Bern, University Hospital Inselspital) has used a device designed to close atrial-septal defects (ASD) to ...
A novel study by Canadian physicians reported that the BioSTAR biodegradable implant achieved comparable closure rates to the Amplatzer Septal Occluder in children with atrial septal defect. A novel ...
TCT 195: Percutaneous Patent Foramen Ovale Closure for Migraine with the Amplatzer PFO Occluder: A Pooled Analysis of Individual Participant Data from the Randomized Trials Receive the the latest news ...
Abbott, a global healthcare leader, announced late-breaking data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrial fibrillation (AFib) who are at an increased ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYS: STJ) , a global medical device company, today announced European CE Mark approval of its AMPLATZER ™ Amulet ™ Left Atrial Appendage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback